Colostrum Market size is estimated at USD 2.09 billion in 2024, to reach USD 2.53 by 2029 to record a CAGR of 3.9% throughout the foreseen period 2024 to 2029.
Colostrum is a milky liquid that comes from the breasts of humans, cows, and other mammals in the first days after calving before milk appears. It contains high levels of proteins, carbohydrates, fats, vitamins, minerals, and proteins (antibodies), which help fight pathogens such as bacteria and viruses. Antibody levels in colostrum can be 100 times higher than in normal cow's milk. Colostrum is taken from cows that have been vaccinated to produce antibodies that fight bacteria that cause diarrheal disease. These antibodies appear in colostrum that are collected as drugs. IGF-I, which is naturally found in colostrum increases the absorption of glucose in the blood and helps transport glucose to the muscles, maintaining energy levels. Colostrum is an important natural substance that helps athletes achieve the desired results. It helps to increase immune function, burn body fat, build lean muscle mass, increase strength and endurance, etc.
In addition, the increasing use of hyperimmune bovine colostrum in various clinical trials for the treatment of transplant-associated diarrhea versus host disease after bone marrow transplantation and rotavirus diarrhea in children is another factor that is expected to drive market growth during the forecast period. However, the risk of stomach infection is an important factor that is expected to limit the adoption of colostrum products, which is an important factor limiting the growth of the global colostrum market to some extent. Increasing R&D activities of key actors in coordination with government research facilities for the development of a vaccine containing colostrum that aids in the treatment of various cancers and other related diseases is expected to create new opportunities of revenue for players operating in the target market forecast period. Furthermore, the growth of strategic public-private alliances for R&D activities is expected to further support the growth of the target market to a large extent.
REPORT METRIC |
DETAILS |
Market Size Available |
2023 to 2029 |
Base Year |
2023 |
Forecast Period |
2024 to 2029 |
CAGR |
3.9% |
Segments Covered |
By Product, Application, and Region. |
Various Analyses Covered |
Global, Regional and Country Level Analysis; Segment-Level Analysis; DROC; PESTLE Analysis; Porter’s Five Forces Analysis; Competitive Landscape; Analyst Overview of Investment Opportunities |
Regions Covered |
North America, Europe, APAC, Latin America, Middle East & Africa |
Market Leaders Profiled |
Key Players In the Global Colostrum Market are Cure Nutraceutical PVT. LTD, NOW Foods, The Saskatoon Colostrum Company, Sterling Technology, Deep Blue Health New Zealand Ltd, PanTheryx, Good Health New Zealand, Biostrum Nutritech Pvt. Ltd. |
The colostrum powder segment was valued at $ 691.3 million in 2023.
It is expected to dominate the market during the forecast period due to its good shelf life when formulated in the manufacture of various Animal and Human Body Nutritional Products. Additionally, these products have been approved for use under the provisions of the United States Food and Drug Administration (FDA) and the Federal Food, Drug, and Cosmetic Act (FFDCA) in the formulation of nutritional products, including beverages, dairy analogs, nutritional bars, and snacks. Consequently, the high protein content of skim colostrum products is expected to promote its usefulness as a sports supplement among health enthusiasts and gym professionals for maintaining body strength and ensuring muscle gain.
The changing lifestyle and shift toward wellness management among working-class professionals in emerging economies, including China and India, should remain a favorable factor. Also, the increasing importance of ensuring adequate nutrition for infants in developed countries, including the United States, Germany, the United Kingdom, and France, should encourage the consumption of products in the form of nutritional supplements for the care of babies. Animal feed is expected to record a CAGR of 4.2% from 2020 to 2025. Feeding a small amount of colostrum to calves can prevent cases of diarrhea and enteritis. In addition, colostrum can provide critical energy in times of hot and cold. The emergence of China and India as fattening chicken manufacturing centers worldwide is expected due to strong demand from countries in the Middle East to drive the application of animal feed. This should boost the utility of colostrum as a functional ingredient in the near future.
Due to growing health awareness among consumers that has fuelled demand for nutritional supplements in the region. According to the Dietary Supplement Survey conducted by the Council for Responsible Nutrition (CRN), more than 76% of American adults consumed vitamins and minerals in supplement form in 2023. The increase in disposable income along with the trend of the boom of sports and physical growth.
Colostrum is widely used in the animal feed industry because it contains a high level of protein, and vitamin D, which is crucial for newborn animals and protects them from environmental pathogens. The increasing emphasis on animal health and care, as well as increased consumption of animal products, will drive regional growth. Colostrum market demand in the Asia Pacific, led by China, India, and Japan, is expected to experience significant growth due to increased demand for infant food products in the region. The Chinese baby food market was valued at more than USD 3 billion in 2023, which will have a positive impact on the growth of the market. A greater focus on adequate infant feeding is expected and the increase in the number of working mothers in countries such as China, India, Japan, South Korea, Thailand, and Malaysia stimulates demand for products during the forecast period.
Key Players In Global Colostrum Market are Cure Nutraceutical PVT. LTD, NOW Foods, The Saskatoon Colostrum Company, Sterling Technology, Deep Blue Health New Zealand Ltd, PanTheryx, Good Health New Zealand, Biostrum Nutritech Pvt. Ltd.
By Product
By Application
By Region
Frequently Asked Questions
Colostrum is the first form of milk produced by mammals, including humans, immediately following the birth of a newborn. It is rich in antibodies, growth factors, and nutrients essential for newborn development and immune support.
Colostrum is collected from mammals, typically cows, within the first 24-48 hours after giving birth. The collection process is carefully managed to ensure the welfare of the animals and to maintain the quality of the colostrum.
Increasing Health Awareness, Rising consumer interest in natural and functional foods
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region